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Damrow, Todd A., M.S., June, 1979 Microbiology 
Host-Parasite Interaction During Tularemia in the Mouse 
Director: J. Frederick Bell 
The subject of host-parasite interaction during tularemia is 
controversial. Uncertainites exist regarding the nature of the host 
response to tularemic infection, and regarding the means by which the 
etiologic agent causes disease. The purpose of this study was to 
investigate the basis of these uncertainties and to attempt resolution 
of them. 
Although Francisella tularensis has generally been considered to 
be a facultative intracellular parasite, the results obtained in this 
investigation indicate that this organism is in extracellular association 
with host mononuclear phagocytes during the disease process in the mouse; 
and in this respect, may be unique among facultative intracellular 
organisms. The following lines of evidence indicate an extracellular 
nature of this organism with regard to mouse peritoneal macrophages: 
1.) 2" tularensis strain Schu S4 was indifferent to the increased 
bactericidal capacity of a BCG activated RES in the mouse, 2.) when 
injected into the peritoneal cavity of mice, jF. tularensis became 
associated with the fluid protion of the peritoneal exudate, whereas. 
Listeria monocytogenes, when injected ip., became associated with the 
cellular portion of the exudate, and 3.) fluorescent antibody staining 
of macrophage cultures inoculated with tularensis strain Schu S4, 
did not reveal the presence of intracellular antigen. 
Specific antibodies have been believed to have an insignificant 
role in the expression of immunity to fully virulent tularemia 
organisms. The results presented in this study do not support this 
belief. The following lines of evidence indicate that antibodies may 
be important in resistance: 1.) specific humoral immunity in combination 
with a nonspecifically activated RES resulted in a degree of protection 
against challenge with _F. tularensis strain Schu S4, 2.) ̂ ^Cr-release 
methodology showed that immune serum influenced the cytopathic effect 
of 2' tularensis strain Schu S4 on cultured macrophages, 3.) pretreatment 
of the organism with immune serum prior to ip. injection, increased 
bacterial association with peritoneal cells, and 4.) immune serum 
enabled cultured macrophages to suppress the growth of the organism in 
cell cultures. 
In the mouse, 2- tularensis strain Schu S4 may not ordinarily be 
ingested by phagocytes, and may be able to overcome host defenses by 
extraphagocytic proliferation and dissemination to sites of specific 
target tissues. Resistance to infection appears to require the 
synergistic cooperation of both humoral and cell-mediated immune 
mechanisms. Specific antibodies control dissemination by promoting 
phagocytosis, while specifically-sensitized macrophages destroy 
ingested organisms by virtue of some specific altered, intrinsic 
quality. 
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CHAPTER I 
INTRODUCTION 
Francisella tularensls is a minute. Gram-negative, pleomorphic, 
nonmotile, aerobic bacterium (16). It was first isolated in 1912 by 
McCoy and Chapin while investigating a plague-like disease among 
ground squirrels in Tulare County, California (81). In 1921, Francis 
named this disease "tularemia" (45). 
Tularemia is a zoonosis. It is primarily a disease of wild 
rodents and other small animals. It is also widespread among 
arthropod parasites. Burroughs et al. (18) ha/e compiled a list of 
48 naturally infected vertebrates. Man is only incidentally involved 
and is usually a dead-end host. Man-to-man transmission is rare. 
The disease can present itself in a variety of clinical forms. In 
animals, tularemia is often an acute, febrile and fatal disease, 
however, subclinical infections and even chronic carrier states are 
not uncommon. In man, tularemia may be a protracted and debilitating 
disease characterized byfwer, nausea, headache, malaise, chills and 
enlargement of the lymph nodes, or it may be a subacute, inapparent 
disease identified only in retrospect by serological procedures (96). 
It is of the utmost importance to specify the virulence of the 
particular strain of F^. tularensis whenever reference to the organism 
is made. Numerous strains of tularensis exist which differ in 
their relative virulences (9). Strains of high virulence are such 
that as few as 1 to 10 organisms may be sufficient to result in a 
fatal infection of susceptible animals. Strains of low virulence, 
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even when administered in large qunatities, may be inocuous and 
used as vaccines. An accepted procedure for quantitation of the 
virulence of 2- tularensis was set forth by Bell et al. (9). 
Because various strains can be expected to react with hosts differ­
ently, specification of virulence is, therefore, critical when 
investigating host interaction with 2- tularensis. 
Coupled with the high virulence of tularensis is the high 
infectivity of this organism. R. R. Parker, as cited by Foshay (44), 
related that he knew of no other disease of animals transmissible to 
man by means so numerous and diverse. Tularemia has ranked high on 
the list of laboratory-acquired infections (98). 
Infection may readily be initiated by contact with the organism. 
F. tularensis has been reported to be able to wen penetrate the 
unbroken skin (46,103). Infected animals constitute a major source 
of infection and serve to transmit the disease to those who may ingest 
or come into contact with such sources, e.g. hunters, trappers, meat 
processors, housewives (96,138). 
Arthropods are vectors of infection for man and may also aid in 
perpetuating the reservoir. Fleas, flies, ticks and mosquitos have 
been implicated as responsible for many reported cases of tularemia 
in man (7,19,48,54). It is of epidemiological interest that the 
greatest incidence of tularemia in the United States in the fall and 
winter months in noted in the Eastern region of the country, while 
the greatest incidence of the disease in the Western region is noted 
i n the spring and summer months. These seasonal occurrences are 
attributed to the popularity of rabbit hunting in the East and to 
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the tick season in the West. 
Another means by which the desease can be transmitted is by 
drinking contaminated water (19,48,103). Bell and Stewart have with 
regularity, isolated _F. tularensis from streams in the Bitterroot 
Valley of Western Montana. The organism has been shown to remain 
viable in natural waters for extended periods, especially in the 
winter (10). Infective water is another means by which the 
reservoir is perpetuated. 
Tularemia may also be contracted via the respiratory route (82). 
Inhalation of dust from hay or straw contaminated with animal feces 
often results in a pulmonary form of the disease (27). An aerosol 
created by the sneezing of an infected laboratory animal has 
purportedly resulted in one known case of tularemia (Bell, personal 
communication). 
2" tularensis has been considered to be a member of the group of 
organisms collectively referred to as facultative intracellular 
parasites. Such organisms are readily ingested by the phagocytic 
cells of the reticuloendothelial system (RES). They are able to 
resist intraphagocytic destruction in nonimmune hosts. Pathogenicity 
is related to their ability to survive and proliferate within host 
cells (122). Other bacteria in this group include species of 
Brucella, Listeria, Pasteurella, Mycobacterium, Salmonella and 
Yersinia. 
Resistance to intracellular infection is dependent on the 
functional capacity of the host cells to inactivate the ingested 
organism (77,80,125); a manifestation of acquired cellular immunity 
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(86,87). This type of immunity iwolves a complex interaction 
between lymphoid cells in the host, and is most often achieved by 
immunization with viable attenuated organisms (22,76). Mackaness, 
a pioneer in advancing the concept of cell-mediated immunity, 
discovered that in mice, immunity to L. monocytogenes could be 
passively transferred to naive recipients with viable spleen cells 
from immune donors (79). Numerous other studies have also shown 
that immunity to intracellular organisms can be transE erred with 
viable lymphoid cells (1,47,63,78,84,127,136). The importance of 
cellular factors in immunity to facultative intracellular parasites 
is also indicated by an association between resistance and the state 
of delayed hypersensitivity (DH) (21,23,28,63,77,123,124). Acquired 
cellular immunity and DH are thought to have similar or closely 
related mechanisms (28,77,97). Resistance to facultative intracell­
ular parasites, however, has also been demonstrated in the absence 
of DH (2,36,37,53,77,106,137). The immunosuppressive effect of anti-
thymocyte globulin on immunity to numerous intracellular organisms 
has implicated the thymus-dependent lymphocytes (T-cells) as being 
the cell subpopulation mainly responsible for the state of acquired 
cellular immunity (20,21,50,68,80,84). A cell-mediated mechanism is 
believed to be responsible for the state of acquired cellular immunity 
to Brucella sp. (36,56,95), Listeria sp. (4,79), enteriditis (92,109) 
and S_. typhimurium (12,12,76). 
Cell-mediated immune responses usually require the participation 
of macrophages (52). Macrophages may act as accessory cells and 
function in the afferent arc of the immune response by processing 
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antigens. They may also function as an effector cell against 
iiNading organisms. Macrophages are often the effector cell in the 
immune response to facultative intracellular infections (108). A 
role for the mononuclear phagocyte was first postulated by 
Metchnikoff in the late nineteenth century. Since that time, much 
evidence has accunulated which documents the importance of the 
macrophage as the effector cell in the prevention of disease. Passive 
transfer of macrophages from resistant animals has been shown to confer 
increased resistance to disease on normal recipients (1,118), while 
the administration of antimacrophage agents to animals has been shown 
to increase host susceptibility to infection (58,70,95,129). Numerous 
in vivo and in vitro investigation have demonstrated that the phago­
cytes of immune animals have greater ingesti/e and digestive abilities 
than cells from nonimmune donors (89,125,126). Lurie (72,73) made 
the initial observation that macrophages from rabbits immune to 
tuberculosis ingested acid-fast bacilli at a greater rate than macro­
phages from nonimmune animals; and that they could inhibit bacterial 
growth when placed in the anterior chamber of the eye of a normal 
rabbit. Further work by Suter (121) showed that macrophages from 
guinea pigs infected with Mycobacterium bovis strain BCG were able 
to suppress the growth of tubercle bacilli in vitro. Mackaness (74) 
demonstrated that prior infection of mice with L. monocytogenes 
enabled their peritoneal macrophages to resist intracellular growth 
of the organism. The time of appearance of the resistant macrophages 
coincided with the disappearance of viable Listeria from the liv er 
and spleen. Thorpe and Marcus (125) reported that rabbit peritoneal 
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macrophages, harvested from immunized animals, had greater cytopeptic 
activities than did the counterpart cells from normal rabbits. Ruskin 
et al. (108) demonstrated that peritoneal macrophages harvested from 
nonspecifically immunized mice were protected against neurotization 
by bacterial and protozoal challenge. 
In its role as an effector cell, the macrophage derives its 
specificity from molecules liberated by specifically sensitized 
T-cells after antigenic stimulation of those cells. Interaction 
between T-cells and macrophages in cellular immune responses is 
mediated by these soluble substances which, in some unknown way, 
alter the physiology of other cells. Researchers have identified 
and characterized a wide range of these lymphoid products (97). The 
elaboration of these soluble mediators by antigen-stimulated lympho­
cytes is believed to be resposible for resistance to infection with 
facultative intracellular parasites. 
Host infection with facultative intracellular organisms often 
results in the induction of nonspecific resistance. Appropriate 
stimulation of host cells may result in cross-protection against 
infection with numerous organisms that have a predilection for intra­
cellular existence (75,77,108). Nonspecific stimulation can be 
enacted by many types of intracellular infections (12,14,36,57,75) 
and also by nonviable agents such as mycobacterial antigens (2,5,32), 
lipopolysaccharides (15,100,107,115,135), simple lipids (25), 
surfactants (26) or complement components (131). Immunization of mice 
with viable BCG has been shown to result in resistance against infection 
with Brucella (120), Listeria (14) and Salmonella (111). This 
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phenomenon of heterologous resistance has been shown to extend beyond 
phyiogenetic lines to include not only bacteria, but a number ot 
protozoa (108), viruses (3,69) and neoplasms (67). This wide range 
d resistance is attributed to the activity of mononuclear phagocytes 
which have increased microbicidal capacities that are not directed 
exclusively against the original infecting organism (51,108). 
Macrophages possessing such activity are commonly referred to as 
being activated. Such cells in vitro are morphologically distinct 
from normal cells (14,75). They appear larger than normal and have 
increased invagination of their cell membrane. They contain greater 
than normal numbers of cytoplasmic digestive vacuoles and lysosomes. 
They have elevated levels of oxidative and hydrolytic enzymes. They 
attach more readily to glass and spread more extensively. The 
ability of these cells to react nonspecifically indicates that a 
common mechanism of immunity underlies intracellular infection. This 
mechanism has not been clearly defined. 
Although there is little dispute that the effector cell responsible 
for immunity to facultative intracellular organisms is the mononuclear 
phagocyte, the role of specific antibodies in resistance is of 
considerable controversy among investigators. Some maintain that 
immunity is primarily due to a change in the intrinsic properties of 
the host cell and that antibodies are of only secondary importance in 
host resistance (12,20,56,75,76,89). Passive transfer of convalescent 
serum has been shown, in many cases, to be ineffective in protecting 
recipients against infection. Organisms in an intracellular environ­
ment are often shielded from humoral factors. The fact that nonbact-
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erial substances are able to induce cross-protection against 
facultative intracellular parasitic infection has been used as 
supportive evidence for the contention that specific antibodies have 
no significant role in resistance to infection by this type of organism. 
Other investigators, however, argue that antibodies have an 
important function in resistance to facultative intracellular parasites 
(36,37,104,105). Numerous in vitro studies have demonstrated that normal 
and immune macrophages are capable of dealing with such parasites only 
if immune serum is present in the culture medium. Phagocytosis and 
inhibition of growth is often less effective if specific antibodies are 
not present. Fong ̂  (40,41) found that macrophages from BCG inoc­
ulated mice were resistant to the cytopathic effect of virulent 
tubercle bacilli only when serum from immune animals was present in 
the culture medium. Jenkin and Benaceraff (59) showed that pre-
treatment of virulent S^, typhimurium with immune serum increased the 
rate at which the organisms were ingested and destroyed by macrophages 
in vitro. Jenkin and Rowley (60) reported that resistance to 
S. typhimurium can be passively transferred with immune serum if 
sufficient quantities were used. Immune serum has been shown to be 
required to prevent virulent B. melitensis from destroying normal 
and immune phagocytes in vitro (36,37). 
The subject of host-parasite interaction during tularemia is 
controversial. Uncertainties exist regarding the nature of the host 
immune response to tularemic infection and regarding the means by 
which the etiologic agent causes disease. 
SGBxe, of the factors involved in immunity against tularemia appear 
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similar to those which are important in resistance to other 
facultative intracellular organisms. Immunity can be passively 
transferred to naive recipients with viable lymphoid cells from 
immune donors, but not always with serum from such donors (1,108,118, 
127,136). Viable vaccines are generally more immunogenic than killed 
vaccines (20,21,31,33,34,42,43,62,110,132). The onset of immunity to 
tularemia can be shown to coincide with the development of DH (20,21, 
95) and the effector cell responsible for acquired immunity to this 
organism is believed to the the macrophage (21,89,95). 
Immunity to tularemia is, however, unlike immunity to other 
facultative intracellular parasites in several interesting respects. 
Resistance to tularemic infection is specific. Claflin (20) and 
Claflin and Larson (21) have shown that the induction of nonspecific 
resistance in mice by immunization with viable BCG does not afford 
protection against challenge with fully virulent tularemia organisms. 
They have also shown that immunization with viable attenuated 
F. tularensis induces no protection against subsequent challenge with 
Z' novicida or typhimurium. It is unusual that this facultative 
intracellular parasite is not only unaffected by nonspecific factors 
of immunity, but that it is also unable to induce such nonspecific 
immunity. Further investigation of these findings would be substantiated. 
The protective efficacy of viable vs nonviable tularemia vaccines 
is an involved subject. To date, the only means of assuring maximum 
immunity has been immunization with living organisms (20,24). Russian 
researchers were the first to report that living avirulent organisms 
were more protective than killed preparations (128). Since that time. 
the superiority of live vaccines has been well documented (20,21,31,33, 
34,42,43,62,95,110,132). Protection from nonviable vaccines depends 
on the natural susceptibility of the animal receiving the vaccine and 
on the virulence of the challenge organism. Killed vaccines have 
been shown to be immunogenic in white rats (17,30,65) and also in 
mice and guinea pigs if challenged with strains of less than full 
virulence (8,42,66,90,93,113). In general, nonviable antigenic 
preparations are protective only 1.) in animals which have a degree 
of natural resistance, and 2.) when strains of low or moderate 
virulence are used as the challenge organism. Explanations of the 
underlying mechanism responsible for this variance in immunogenicity 
are scanty. 
Disagreement exists regarding the role of specific antibodies 
in immunity to tularemia. It has generally been held that antibodies 
are only of secondary importance in the host response to tularemic 
infection. More recently, however, reports have appeared in the 
literature which suggest that antibodies may assume an active and 
important role in resistance. These reports have also challenged the 
contention that tularensis is in intracellular association with 
host phagocytes during the the disease process. Further investigation 
of this matter would be in order. 
The _F. tularensis - mouse system provides a particularily 
lucrative model for investigating host interactions with facultative 
intracellular organisms. There is little, if any, chance that 
laboratory animals have been previously exposed to thes agent : an 
important consideration when experimenting with Gram negative bacteria. 
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Small numbers of organisms are sufficient to result in infection 
and usually lead to an acute and fatal disease. Endotoxin is not a 
complicating factor in the pathogenesis of the disease. Except for a 
single report (64), no endotoxin-like material has been isolated or 
boivin antigen detected (100,101). Also, bacterial strains of 
varying degrees of virulence are available to the researcher, as are 
experimental hosts differing in susceptibility. 
Statement of Problem 
Francisella tularensis has generally been considered to be a 
facultative intracellular parasite whose pathogenicity may be a 
consequence of intraphagocytic multiplication. Specific antibodies 
have been considered to be only of secondary importance in host 
resistance. These beliefs have recently been challenged by reports 
which suggest that F. tularensis may overcome host defenses primarily 
by extraphagocytic growth and that antibodies may in fact, be essential 
for host resistance. The subject of host-parasite interaction during 
tularemia remains an area of controversy. This study was undertaken 
to investigate the basis from which ambiguities have arisen and to 
attempt resolution of them. 
CHAPTER II 
MATERIALS AED METHODS 
Animals 
Outbred Swiss-Webster mice between 4 and 8 weeks of age, 
obtained from the colony at Rocky Mountain Laboratory, U.S. Public 
Health Service, Hamilton, Montana, were used throughout this invest­
igation. 
Adult, New Zealand white rabbits, obtained from the above 
institution served as the source of sera for cell culture media and 
passive transfer studies. All animals were allowed food and water 
ad libitum. 
Organisms 
Strains of F^. tularensis were obtained in lyophilized form from 
Dr. J. F. Bell, U.S. Public Health Service, Rocky Mountain Laboratory, 
Hamilton, Montana. The organisms were maintained on glucose cysteine 
heart agar (Difco) supplemented with fresh defibrinated rabbit blood 
to a final concentration of 5%. tularensis strain Schu S4, 
isolated by Foshay in 1941 is a strain of high virulence. It has a 
LD5Q of 1-10 colony forming units (CPU) in mice, guinea pigs and 
rabbits. ]F. tularensis strain 425 F4G was isolated by Bell (9) 
from a tick in Western Montana. It is a highly virulent strain in 
mice and guinea pigs (LD^g: I-J.0 CPU), but of lower virulence in the 
rabbit. The live vaccine strain (LVS), developed by Russian scientists 
(128) and currently used in the United States as a live vaccine against 
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tularemia, is of low virulence in mice (LD^g; 10^-10^ CFU). 
Lyophilized lots of the various strains were established. Periodically, 
ampules were rehydrated and the contents cultured on glucose cysteine 
blood agar (GCBA) plates (29,49). Prior to use, the organisms were 
reisolated twice from experimentally-infected mice to ensure full 
virulence of the strain. 
Suspensions of challenging or immunizing doses were prepared in 
sterile physiological saline-gelatin solution (0.1% gelatin & 0.15% NaCl) 
(sal-gel) from 24^48 hr cultures of the organism. The suspensions were 
adjusted to an appropriate concentration based on turbidometric readings 
in the Klett-Summerson photoelectric colorimeter fitted with a #42 blue 
filter. Concentrations of viable organisms in suspension were 
determined by standard plate counting techniques. One-tenth ml 
volumes of appropriate dilutions were plated on each of 3 GCBA plates 
and incubated at 37 ®C for 24-48 hr. Klett-250 suspensions (zero 
dilution) of F^. tularensis routinely contained 10^-10^0 CFU per ml. 
A culture of Mycobacterium bovis strain BCG-Paris was obtained 
through the courtesy of Dr. C. L. Larson, Stella Duncan Memorial 
Research Institute, University of Montana, Missoula, Montana. The 
organism was maintained as described below. 
Cultures of I^. monocytogenes and typhimurium were kindly 
provided by Mr. Richard L. Hodinka, Department of Microbiology, 
University of Montana, Missoula, Montana and maintained on Trypticase-
Soy agar (Difco) plates at 4 C. The organisms has mouse LD^g values 
of 103'7 and 10^*^ CFU respectively. 
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A culture of novicida was obtained from the stock culture 
collection at Rocky Mountain Laboratory, U.S. Public Health Service, 
Hamilton, Montana, and maintained on GCBA plates. This organism had 
a mouse LD^Q of 10^"^ CPU. 
Vaccines 
Ether-extracted antigen (EEA) was prepared from 2- tularensis 
strain Schu S4 according to the method of Larson (65). Flasks 
containing Snyders peptone broth (116) were inoculated with the 
organism and incubated at 37 *C for 48 hr on a shaker. Cells were 
harvested by centrifugation at 8,000 x g for 30 min and washed 3 times 
in sal-gel. The sedimented cells were then resuspended in sal-gel and 
treated with an equal volume of ethyl ether for 24 hr at room temp­
erature with occasional shaking. The ether phase was drawn off and 
gaseous nitrogen passed through the aqueous phase to evaporate 
residual ether. The remaining solution, now designated EEA, has been 
reported to be a crude suspension of pôlydisperse cell wall fragments 
(90). The suspension was then adjusted to a Klett reading of 100 
with sal-gel and stored a 4 *C in sealed serum vials. Absence of 
viable organisms was confirmed by plate culture and by mouse inoc­
ulation. An immunizing dose consisted of 0.2 ml, and was injected 
into â tail vein of the mice. Antigenicity was confirmed by a 
positive capillary tube precipitation reaction and by titer determ­
inations on injected animals. 
Viable BCG was prepared according to a protocol maintained at 
the Stella Duncan Memorial Research Institute, University of Montana, 
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Missoula, Montana. Flasks of Dubos medium (Difco) were inoculated 
with Mycobacterium bovis strain BCG-Paris, from a culture maintained 
on Hohns medium (Difco). The cultures were incubated at 37 for 
7-9 days, passed to fresh Dubos medium and allowed to incubate 
another week. The cells were then harvested by centrifugation at 
4,080 X g for 30 min and washed 3 times in Dubos medium. The cells 
were resuspended in Dubos medium and adjusted to a density of 200 
Klett units. The vaccine was stored at -70 in sealed serum vials. 
Purity was checked by Ziehl-Nielson acid-fast staining. The working 
vaccine was readied by diluting the suspension 1:1 with Dubos medium. 
A standard immunizing dose of 0.2 ml was injected into a tail vein of 
the mice. This amount corresponded to approximately 250^g wet weight 
of bacteria and 7 x 10^ CFU. Efficacy of this vaccine was tested by 
injecting groups of mice and 3 weeks post^injection, determining the 
presence of 1.) splenomegaly, 2.) delayed hypersensitivity to 
purified protein derivative (PPD), and 3.) nonspecific resistance. 
Serologic tests 
Bacterial agglutination titers were conducted on serum samples 
according to standard tube agglutination procedures. A stock 
suspension of formalin-killed _F. tularensis strain 425 F^G was 
prepared (approximately 1 x 10^ cells per ml) and used as the 
agglutinogen. The stock suspension was diluted 1:300 to obtain the 
working solution. Serial 2^ fold dilutions (0.5 ml) were made for each 
serum sample with saline, and equal volumes of the agglutinogen were 
added to each tube. The agglutination titer was determined as the 
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reciprocal of the highest dilution of serum showing positive 
agglutination after overnight incubation at 37 "C. 
Passive transfer of sera 
New Zealand white rabbits were injected sc. with approximately 
1 X 10^ viable F^. tularensis strain Schu S4 organisms and streptomycin 
therapy was initiated 3 days later (daily im. injections of 200 mg 
streptomycin sulfate for 5 days). When recovery was assured, the 
rabbits were anesthesized with sodium pentobarbital and exsanguinated. 
Sera were separated and pooled. Volumes of 0.5 ml were injected into 
a tail vein of the recipient mice 1 hr before bacterial challenge and 
again at 1 hr after challenge. 
Protection tests 
Protection against a challenge infection was measured in terms 
of survival after injection with serial 10-fold dilutions of challenge 
organism into separate groups of mice. Experimental and control 
groups of 10-15 mice each were injected sc. with 0.5 ml of each 
dilution. Deaths among challenged mice were recorded daily for 14 
days. The LD^g and the mean time to death (MTD) were calculated for 
each group. 
In vitro studies 
Mouse peritoneal adherent cells were used in vitro correlate 
experiments to host-parasite interaction. To collect the cells, mice 
were killed by cervical dislocation and injected ip. with 5.0 ml of 
Dulbecco's phosphate buffered saline (PBS) containing 5 units of 
heparin per ml. Eliciting agents or irritants were not used to obtain 
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higher yields of cells because it has been demonstrated that results 
will vary with different elliciting agents (24,38,83). After gentle 
kneading of the abdomen, the surrounding skin was swabbed with 70% 
ethyl alcohol and reflected back. The peritoneal sac was punctured 
aseptically and the enclosed fluid was allowed to drain into sterile, 
cold, siliconized, glass centrifuge tubes. Bloody exudates were 
discarded. Following centrifugation at 500 x g for 5 min, the 
supernatant fluid was discarded. Sedimented cells were washed 3 
times in Dulbecco's PBS + heparin, treated with Tris-NH^Cl for 10 min 
at room temperature and washed again. The cells were then suspended 
to the desired seeding concentration in cell culture mainenance 
medium (RPMI supplemented with 20% heat inactivated rabbit serum, 
200 unit s/ml penicillin and 2.5 /<g/ml fungizone). Cell suspensions 
were placed in appropriate culture vessels and allowed to incubate for 
45 min at 37 in a 5% CO2 atmosphere. The cultures were then washed 
to remove nonadherent cells. 
The in vitro experimental setup (Fig. 1) was designed to 
correlate with antecedent in vivo experiments. Two variables existed; 
1.) the immune status of the macrophage source, and 2.) the type of 
serum present in the cell culture medium. The cell cultures were 
inoculated with F^. tularensis strain Schu S4 and two parameters were 
investigated; 1.) the fate of the macrophages, and 2.) the fate of the 
inoculum. 
In vitro cytopathology assays 
Cell count method - Mouse peritoneal macrophages were cultured in 
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1 
O 
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Fig. 1. Experimental setup used in determining the effect of 
macrophage source and specific antibody on macrophage 
viability and bacterial growth in cell cultures 
inoculated with F. tularensis strain Schu S4. 
^Cultures were inoculated at a ratio of approx. 10 bacteria/macrophage. 
^Mice were immunized iv. with viable BCG (7 x 10^ CFU, 250/4 g ^et wt) 
3 weeks prior to harvesting of macrophages. 
^Mice were given a 1^ injection sc. of approx. 10^ viable LVS organisms 
and a 2® injection 2 weeks later of approx. 10^ viable Schu S4 organisms. 
Macrophages were harvested 3 weeks after 2® injection. GCBA plate 
cultures of harvested cells at this time yielded no viable bacteria. 
^Serum was obtained from rabbits which had been injected sc. with approx. 
10^ viable Schu S4 organisms and treated with streptomycin (daily im. 
injections of 200 mg streptomycin sulfate, initiated 3 days post-injection). 
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Lab-Tek* cell culture chamber slides. Prior to seeding of the cells, 
circles of approximately 1 mm in diameter were etched on the surface 
of the glass floor of each culture chamber by means of a diamond-
point pencil and a template. The etching fragments were removed and 
the cell culture chamber slides were disinfected by UV irradiation. 
Macrophage cultures were established in the chambers. Photomicro­
graphs were made of the cells contained within the inscribed area 
of the chamber with a Nikon model F2 inverted microscope coupled to 
a polaroid photoattachment adapter cone fitted with a 1.3X lens and 
a 4" X 5" type 55 PN back and an AFM exposure control. Macrophage 
cultures were inoculated with %. tularensis strain Schu S4 at a 
ratio of approximately 10 bacteria per macrophage. Photomicrographs 
of the circumscribed cells were made daily for 7 days. Cultures 
were washed before photographing to remove cells which had become 
nonadherent. Cell counts were conducted on the photomicrographs, 
and the decrease in the number of viable, adherent cells was recorded. 
51cr-release method - Mouse peritoneal exudate cells were 
harvested and processed as previously described. The cells were 
incubated in the presence of radioactive Na2^^CrO^ at a concentration 
of approximately lOOyyci/lO^ macrophages in a 37 ®C water bath for 
30 min with occasional shaking. After 3 washings in cold RPMI medium 
to remove nonincorporated label, the cells were resuspended in RPMI 
medium and seeded at a concentration of approximately 10^ cells per ml. 
in plastic screw-top test tubes. Following an incubation period of 
45 min, the nonadherent cells were removed by washing. Radioisotopic 
counts were made after withdrawing the culture medium and inserting 
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the culture vessel into a Nuclear model 8775 gamma counter. Culture 
medium was replaced after the readings. Macrophage cultures were 
inoculated with tularensis strain Schu S4 and counts of the 
radioactivity remaining in the adherent cells were made at 12 hr 
intervals for 5 days. Background radiation was counted and recorded. 
Cytopathology was measured by determining the rate at which the 
label was released from the adhered macrophages. 
In vivo phagocytosis of bacteria by mouse peritoneal cells 
In vivo phagocytosis of 2- tularensis and L. monocytogenes by 
mouse peritoneal cells was determined by the method of Taplits and 
Myrvik (124). Bacterial suspensions were injected ip. into groups of 
5 mice each. One hr after injection, the peritoneal cavities were 
las/aged and the exudates were centrifuged in siliconized centrifuge 
tubes at 480 x g for 5 min. Cell-associated and supernatant-
associated bacteria were assayed by plating serial dilutions of the 
respective fractions. The data are presented as the percent of the 
total bacteria recovered. 
Immunofluorescence 
Fluorescein isothiocyanate-conjugated antitu larensis immuno­
globulin had been prepared by Mr. Scott J. Stewart, Rocky Mountain 
Laboratory, U.S. Public Health Service, Hamilton, Montana, according 
to the method of Peacock, et al. (94), and was used to stain 
macrophages from cultures which had been inoculated with IF. tularensis. 
Macrophage cultures were inoculated with 2- tu larensis at a ratio of 
approximately 50 bacteria per macrophage. The cells were incubated 
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until cytopathology was first noted. The cultures were then washed, 
and the cells were fixed in acetone at -70 for at least 12 hr. 
The cells were stained as described in a protocol by Bell (unpublished) 
and viewed in a Leitz-Wetzlar Ortholux Il/Diayert fluorescent 
microscope equipped with a 35 mm Orthomat W camera. Appropriate 
controls were included. 
CHAPTER III 
RESULTS 
Attempt to induce nonspecific imnunity to F. tularensis strain Schii S4 
This study stemmed from the finding by Claflin and Larson (21) 
that immunization of white mice with viable BCG afforded no cross-
protection against subsequent challenge with 2» tularensis strain Schu 
S4. Viable BCG, when administered to animals, typically results in 
nonspecific stimulation of the recipients' RES. Such stimulation has 
been shown to be effective in inducing protection against infection 
with numerous etiologic agents. It appeared unusual that 2* tularensis 
should be virtually unaffected by nonspecific factors of immunity. 
A preliminary experiment was conducted to confirm this earlier 
finding of Claflin and Larson (21). Groups of mice were injected iv. 
with viable BCG (7 x 10^ CFU, 250/(g wet wt). After a period of 3 
weeks, when nonspecific resistance was at its height (D. Lodmell and 
C. L. Larson, unpublished data), groups of mice were challenged sc. 
with serial 10-fold dilutions of tu larensis strain Schu S4. At 
this time, it was determined that the inoculated mice had a 4.7X 
splenomegaly compared to noninoculated controls. Attempts to demon­
strate DH to PPD were unsuccessful. Separate groups of mice were also 
challenged with serial 10-fold dilutions of monocytogenes, 
typhimurium, and with 2- novicida. Table I shows that inoculation 
of mice with viable BCG did not result in protection against challenge 
with IF. tularensis strain Schu S4. Results shown in Table II indicate 
that this BCG vaccine was capable of inducing nonspecific resistance. 
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Table I. Attempt to Induce nonspecific resistance to sc. challenge 
with 2" tularensis strain Schu S4 in mice immunized 3 weeks previously 
with viable BCG (7.0 x 10^ CFU, 250)i(g wet wt) injected iv. 
Number of 
challenge 
BCG immunized mice Control mice 
organisms 
(CFU) d/t* MTD^ d/t MTD 
loi 10/10 5.7 ± 0.7 10/10 5.1 ± 0.6 
10^ 10/10 5.0 + 0.7 10/10 5.0 ± 0.0 
10^ 10/10 4.5 ± 0.5 10/10 4.5 ± 0.5 
104 10/10 4.3 ± 0.7 10/10 4.1 ± 0.6 
10^ 10/10 4.1 ± 0.3 10/10 4.1 ± 0.3 
10^ 10/10 4.2 ± 0.5 10/10 4.0 ± 0.0 
10? 10/10 3.8 + 0.8 10/10 3.1 ± 0.7 
10® 10/10 3.5 + 0.5 10/10 3.1 ± 0.6 
LD30 < loi < loi 
LogSjQ protection 0 
^Deaths per total mice challenged. 
^ean time of death (days) ± S.E. 
Table II. Ability of viable BCG to induce nonspecific resistance to sc. 
challenge with I,, monocytogenes, typhimurium and novicida*. 
Number of 
Challenge organism 
challenge 
organisms 
L. monocytogenes S. typhimurium F. novicida 
(CFU) Control BCG Immune Control BCG Immune Control BCG Immune 
10^ 0/5% 0/5 1/5 0/5 0/5 0/5 
102 1/5 0/5 3/5 0/5 3/5 0/5 
10^ 3/5 0/5 4/5 1/5 3/5 0/5 
10^ 2/5 1/5 5/5 3/5 4/5 0/5 
105 4/5 0/5 5/5 3/5 5/5 0/5 
10^ 4/5 0/5 4/5 3/5 5/5 1/5 
107 5/5 1/5 5/5 5/5 4/5 3/5 
108 5/5 2/5 5/5 5/5 5/5 4/5 
LD50 103.7 >108.0 102.0 104.4 102-7 106.8 
togs^o protection > 4. 3 2.4 4 .1 
*Mice were challenged sc. 3-weeks after iv. injection, of viable BCG (7.0 x ID^ CFU, 250 /(g wet wt). 
^Deaths per total mice challenged» 
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Effect of BCG immunization on inf ection with IF* tularensis strains of 
reduced virulence 
Highly virulent 2- tularensis strain Schu S4 has been shown to 
be unaffected by nonspecific factors of immunity. It was desired 
to know whether this finding applies to 2' tu larensis strains of 
reduced virulence. The preceeding experiment was repeated using 
2" tularensis strain 425 F^G and strain LVS as the challenge organisms. 
Data presented in Table III show that nonspecific activation of the 
RES resulted in a degree of protection against the strains of reduced 
virulence. Although BCG immunization did not protect against mortality 
in mice challenged with IF. tu larensis 425 F^G, a significant increase 
in the mean time of death was noted. Protection against challenge 
with 2* tularensis strain LVS was manifest as both a decrease in 
mortality and an increase in the mean time of death of the fatalities. 
Coupled with the results presented in Table I, it can be observed 
that the degree of protection against tularemic infection, attributable 
to RES activation, is inversely related to the virulence of the 
particular infecting strain. Subsequent investigation will be centered 
primarily on host interaction with F. tularensis strain Schu S4. 
Table III. Protective effect of immunization with viable BCG on mice challenged sc. with F^. tularensis 
strain LVS and strain 425 F^G®. 
Number of 
challenge 
organisms 
Strain of F. tularensis 
LVS 425 f4g 
Control BCG immune Control BCG immune 
d/tb MTDC d/t MTD d/t MTD d/t MTD 
10^ 0/10 - 0/10 - 10/10 6.4 ± 0.5 10/10 8.8 ± 0.8 
102 0/10 - 0/10 - 10/10 6.2 ± 0.4 10/10 8.1 ± 1.2 
103 3/10 7.6 ± 0.6 0/10 - 10/10 5.8 ± 0.4 10/10 
+1 0
0 
1.2 
104 8/10 6.3 + 0.9 0/10 - 10/10 5.4 ± 0.7 10/10 7.2 ± 1.8 
105 10/10 6.4 + 1.0 0/10 - 10/10 5.1 ± 0.3 10/10 6.9 ± 1.3 
10^ 10/10 5.0 + 0.8 4/10 6.8 ± 0.5 10/10 4.5 ± 0.7 10/10 5.8 ± 1.2 
10^ 10/10 4.4 + 0.8 9/10 5.1 ± 0.6 10/10 4.2 ± 0.4 10/10 6.6 ± 1.6 
10® 10/10 4.2 + 0.8 10/10 4.7 ± 0.5 10/10 3.7 ± 0.3 10/10 5.6 ± 1.4 
ld50 10^ 
.4 106.2 < 10 1.0 
0
 
r—1 0
 
f—
1 v
 
Logsio protection 2.8 0 
^Mice were challenged sc. 3 weeks after iv. injection of viable BCG (7 x 10^ CFU, 250^g wet wt). 
^Deaths per total mice challenged. 
^Mean time of death (days) ± S.E. 
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The combined effect of specific humoral immunity and nonspecific RES 
activation on resistance of mice to . tularensis strain Schi S4 
C. L. Larson (personal communication) suggested that a BCG 
activated RES might require the presence of specific antibodies for 
the expression of resistance to infection with fully virulent strains 
of tularensis. In the following 2 experiments, the combined effect 
of specific antibodies and BCG immunization on the resistance of mice 
to 2' tularensis strain Schu S4 was determined. A humoral response 
was established by: 1.) active immunization with a bacterial antigen, 
or 2.) passive administration of immune serum. 
Experiment - Specific active immunization with EEA combined with 
nonspecific RES activation by viable BCG. 
Groups of mice were injected with EEA, BCG or both. Mice were 
inoculated with 0.2 ml of a Klett-100 suspension of EEA, followed by 
a similar injection 2 weeks later. Agglutination tests with a 
F. tularensis antigen revealed that the response of the mice to EEA 
was highly variable (Table IV). Mice inoculated with EEA were 
challenged sc. with serial 10-fold dilutions of _F. tularensis strain 
Schu S4 1 week after the second inoculation. To investigate the 
combined effect of a specific and nonspecific vaccine, mice, which 
had been inoculated with a primary dose of EEA 2 weeks previously, 
were injected iv. with a Klett-200 suspension of viable BCG that had 
been diluted 1:1 with a Klett-100 suspension of EEA. The mice were 
challenged 3 weeks later as described above. 
The results from a typical experiment are shown in Table V and 
Fig. 2. None of the immunization regimes resulted in protection against 
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Table IV. Antibody response of mice to primary and secondary 
Immunization with EEA^. 
Agglutination titer 
Sample 
number 2 weeks post-1* Injection 1 week post-2* Injection 
1 <4 16 
2 8 128 
3 8 4 
4 <4 32 
5 4 32 
6 4 64 
7 <4 128 
8 8 128 
9 4 64 
10 4 32 
®Mlce were Injected Iv. with 0.2 ml of a Klett-100 suspension of EEA 
and reinjected 2 weeks later with an equal dose. 
Table V. Effect of specific immunization with EEA and nonspecific immunization with viable BCG on 
mice challenged sc. with serial 10-fold dilutions of F. tularensis strain Schu S4, 
10^ 10/10 5.1 + 0.6 10/10 6.3 + 1.2 10/10 5.7 + 0.7 10/10 10.2 + 1.8 
102 10/10 5.0 + 0.0 10/10 5.4 ± 0.8 10/10 5.0 + 0.7 10/10 7.9 + 1.1 
10^ 10/10 4.5 + 0.5 10/10 5.0 ± 0.7 10/10 4.5 + 0.5 10/10 7.3 + 1.4 
104 10/10 4.1 + 0.6 10/10 5.1 ± 0.9 10/10 4.3 + 0.7 10/10 6.9 + 0.9 
105 10/10 4.1 ± 0.3 10/10 4.9 + 1.6 10/10 4.1 + 0.3 10/10 6.1 + 0.3 
10^ 10/10 4.0 + 0.0 10/10 4.8 ± 0.8 10/10 4.2 + 0.5 10/10 6.4 + 0.7 
10? 10/10 3.1 + 0.7 10/10 3.8 + 0.9 10/10 3.8 + 0.8 10/10 6.2 + 0.8 
10® 10/10 3.1 + 0.6 10/10 3.7 ± 0.8 10/10 3.5 + 0.5 10/10 5.1 + 0.6 
Treatment 
organisms 
d/t' 
/
/
/
/
/
mtd' 
± 
± 
± 
± 
±
± 
± 
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d/t 
/
/
/
/
/
/
/
mtd 
± 
±
± 
BCG 
d/t 
/
/
/
/
/
/
/
/
mtd 
± 
± 
± 
±
± 
± 
± 
± 
EEA & BCG 
d/t MTD 
± 
± 
± 
± 
± 
± 
± 
± 
LD50 < 10^ <ior <10^ < lOl 
^Deaths per total mice challenged, 
^ean time of death (days) ± S.E. 
I I I 1 I I I 
102 103 105 106 io7 io8 
NUMBER OF CHALLENGE ORGANISMS 
Effect of specific immunization with EEA and nonspecific immunization with viable 
BCG on the mean time of death of mice challenged sc. with serial 10-fold dilutions 
of 2* tularensis strain Schu S4. Normal mice O o ; EEA immune mice • • ; 
BCG immune mice # # ; EEA and BCG immune mice A —A • 
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mortality. Specific active immunization in combination with 
nonspecific immunization with viable BCG, however, resulted in a 
low order of protection as expressed by a statistically significant 
increase in the mean time of death of the challenged mice. 
Experiment 2. - Passive transfer of immune serum combined with 
nonspecific RES activation by viable BCG. 
As in Experiment 1, four experimental groups existed: 1.) an 
immunologically naive, control group of mice; 2.) a group of mice 
with specific circulating antibodies; 3.) a group of mice which had 
a BCG activated RES; and 4.) a group of mice with both specific 
humoral antibodies and a nonspecifically activated RES. Immune 
rabbit serum (agglutination titer: 1024) was injected in 0.5 ml 
amounts into a tail vein of recipient mice 1 hr before challenge with 
serial 10-fold dilutions of _F. tularensis strain Schu S4, and again 
at 1 hr after challenge. Normal rabbit serum was likewise injected 
as a control into appropriate recipient groups. To investigate the 
combined effects of specific antibodies and a nonspecifically 
stimulated RES, sera were passively transferred to recipient mice 
which had been inoculated 3 weeks previously with viable BCG. The 
rate of clearance of rabbit antibodies from recipient mice was 
determined (Table VI and Fig. 3). 
The results presented in Table VII and Fig. 4 essentially 
parallel the results of the previous experiment. None of the 
immunization regimes protected against mortality, however, degrees 
of protection were detected by observing the mean time of death of 
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Table VI. Antitularensis titer determinations on mice, following 
passive transfer of Immune rabbit serum^. 
Sampling time^ Agglutination titer 
0 hr 512 
3 hr 512 
6 hr 512 
12 hr 256 
1 day 256 
2 day 256 
3 day 128 
4 day 128 
5 day 128 
6 day 128 
7 day 128 
8 day 64 
^Mice were injected iv. with two 0.5 ml volumes of rabbit antitularensis 
serum, separated by a 2 hr interval (agglutination titer; 1024). 
^Time 0 hr; immediately following second serum injection. 
600 -I 
1 2 3 4 5 6 7 8 
T IME (days )  
Fig" 3. Clearance of rabbit antitularensis immunoglobulin from recipient 
mice. Mice were injected iv. with two 0.5 ml volumes of rabbit 
antitularensis serum (separated by a 2 hr interval). Time 0; 
immediately following second serum injection. Titers were 
determined on sera pooled from 5 mice per sampling time. 
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of the fatalities. There was a slight degree of protection noted 
among the group of normal mice receiving immune serum attributable 
to the effect of the specific antibodies. RES activation alone 
resulted in no significant deviation from control values. Specific 
antibodies in conjunction with nonspecific RES activation afforded 
the greatest degree of protection to the challenged mice as 
revealed by prolongation of survival. 
Table VII. Effect of passive transfer of immune rabbit serum and nonspecific immunization with viable 
BCG on mice challenged sc. with serial 10-fold dilutions of F. tularensis strain Schu S4. 
10^ 10/10 5.4 + 0.5 10/10 8.2 + 0.8 10/10 6.6 + 0.7 10/10 11.8 + 
10^ 10/10 5.0 + 0.7 10/10 7.6 + 0.6 10/10 5.6 + 0.6 10/10 10.8 + 
103 10/10 4.6 + 0.9 10/10 7.2 + 0.5 10/10 5.8 + 0.5 10/10 8.6 + 
10^ 10/10 4.2 + 0.5 10/10 6.6 + 1.1 10/10 4.6 + 0.6 10/10 8.0 + 
105 10/10 4.2 + 0.5 10/10 5.4 + 0.6 10/10 5.0 + 0.0 10/10 7.8 + 
V
O
 0
 
1—
1 
10/10 4.0 ± 0.0 10/10 5.8 + 0.5 10/10 4.0 + 0.7 10/10 7.0 + 
10? 10/10 3.2 + 0.5 10/10 4.8 ± 0.8 10/10 4.2 + 0.5 10/10 6.4 + 
10® 10/10 3.0 ± 0.0 10/10 5.0 ± 0.0 10/10 3.6 + 0.6 10/10 6.7 + 
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-
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^Deaths per total mice challenged. 
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Fig, 4. Effect of passive transfer of immune rabbit serum and nonspecific immunization with 
viable BCG on the mean time of death of mice challenged sc. with serial 10-fold 
dilutions of jP. tularensis strain Schu S4. Normal mice, normal serum O O ; 
normal mice, immune serum • • ; BCG immune mice, normal serum e e ; 
BCG immune mice, immune serum A A « 
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In vitro correlates to host-parasite interaction 
The preceeding vivo studies produced unusual and interesting 
results. Rirther investigation was conducted in vitro in order to 
obtain more experimental control over this host-parasite system. 
Macrophages were used as the cell type in this vitro system 
because it is generally believed that the prime mediator of protection 
against facultative intracellular bacterial infections is a cellular 
immune mechanism residing in the macrophage population. 
Differential cell counts, conducted on Wrights and Giemsa 
stained cell cultures, revealed that the cell population, as 
determined by morphological criteria, consisted of greater than 95% 
mononuclear leucocytes (Fig. 5). Functional testing by latex 
particle ingestion showed that greater than 95% of the cells were 
phagocytic (Fig. 6). It is with these qualifications that the cells 
are referred to as macrophages. 
Experiment 1. - Determination of macrophage viability via cell counts 
after inoculation of cultures with 2- tularensis strain Schu S4, 
Cell counts of adherent (viable) macrophages were conducted 
daily on photomicrographs of cells which were contained within etched 
areas on the culture vessel floors. A typical photomicrograph, from 
which counts were made, is presented in Fig. 7. Cell counts were 
made with the aid of an acetate sheet overlay and a marking pen. The 
mmber of cells adherent within the enscribed area was monitored for 
5 days. 
Results are shown in Table VIII and Fig. 8-10. This particular 
assay method apparently lacked sensitivity as evidenced by deviations 
in cell counts and by wide fluctuations in the slope of the 
corresponding graphs. The assay was not repeated an adequate number 
of times to determine the standard error because of reason presented 
below. Conclusions from the results of this experiment were not 
made. The results do, however, evoke inferences that 2- tularensis 
strain Schu S4 had a cytopathic effect on macrophages harvested 
from normal and BCG immunized mice, but not on macrophages harvested 
from mice specifically immunized with viable tularemia organisms. 
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Fig. 5. Mouse peritoneal adherent cells maintained in RPMI 
medium containing 20% rabbit serum, and stained by 
a modified Giemsa method. 2000X. 
Fig. 6. Mouse peritoneal adherent cells maintained in RPMI 
medium containing 20% rabbit serum, 5 min after 
inoculation with 1.0/<m diam. polystyrene latex 
particles, and stained by a modified Giemsa method. 
2000X. 
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Fig. 7. Mouse peritoneal adherent cells maintained in RPMI medium 
containing 20% rabbit serum, as they appeared at time 
of challenge, with delineated area etched in the floor 
of the culture vessel. 50X. 
Table VIII. Effect of 2- tularensis strain Schu S4 on the viability of macrophages of various immune 
status, cultured in medium containing normal vs immune rabbit serum. 
Macrophage 
source 
Type of 
rabbit serum 
Experimental 
group 
Days post-inoculâtion 
12 3 4 
Nonimmunized 
mice 
Normal 
Immune 
Control 1,507® 1,403 1,426 1,310 1,273 1,256 
Inoculated 1,694 1,385 882 729 702 676 
Control 1,618 1,515 1,355 1,429 1,504 1,467 
Inoculated 1,550 1,264 1,056 584 699 572 
BCG immunized 
mice 
Normal 
Immune 
Control 
Inoculated 
Control 
Inoculated 
1,708 
1,420 
1,575 
1,625 
1,363 
1,021 
1,654 
1,694 
1,208 
826 
1,351 
972 
1,472 
688 
1,440 
615 
1,361 
838 
1,299 
392 
1,377 
641 
1,223 
327 
Specifically 
immunized 
mice 
Normal 
Immune 
Control 
Inoculated 
Control 
Inoculated 
1,599 
1,437 
1,537 
1,667 
1,422 
1,344 
1,207 
1,595 
1,457 
1,407 
1,443 
1,526 
1,329 
1,250 
1,381 
1,603 
1,198 
1,037 
1,337 
1,550 
1,133 
969 
1,235 
1,474 
%umber of macrophages adhered within delineated area. 
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Fig. 8. Viability of normal mouse peritoneal macrophages, cultured 
in medium containing normal vs immune rabbit serum, and 
inoculated with F. tularensis strain Schu S4. Inoculated • ; 
noninoculated o ; normal serum in medium ; immune 
serum in medium • . 
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Fig. 9. Viability of macrophages from BCG immunized mice, cultured 
in medium containing normal, vs immune rabbit serum, and 
inoculated with tularensls strain Schu S4. Inoculated • ; 
noninoculated o ; normal serum in medium ; jjnmune 
serum in medium ••• . 
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Viability of macrophages harvested from mice specifically 
immunized with viable 2- tularensis, cultured in medium 
containing normal vs immune rabbit serum, and inoculated 
with 2» tularensis strain Schu S4. Inoculated • ; 
noninoculated o ; normal serum in medium ; immune 
serum in medium • . 
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Experiment 2. - Determination of macrophage cytopathology via ^^Cr-
release after inoculation of cultures with _F. tularensis strain Schu S4. 
The previous cell count method for determining the effect of 
Z* tularensis strain Schu S4 on cultured macrophages was considered to 
be excessively crude. A quicker, simpler, more sensitive and more 
reproducible method for assaying cytopathology was applied, viz ^^Cr-
release. 
Cultures of ^^Cr-labelled macrophages were inoculated with 
2' tularensis strain Schu S4 at a ratio of approximately 10 bacteria 
per macrophage. The amount of label released from the cells was 
monitored at 12-hr intervals fro 5 days by removing the culture 
medium, inserting the culture vessel into a gamma counter and 
measuring the amount of radioactivity emitted. 
Tables IX-XII and Fig. 11-13 show the effect of the various 
macrophage source/sera combinations on macrophage cytopathology. The 
loss of label from cells in noninoculated cultures is due to the natural 
permeability of the macrophage cell membrane and to radioisotopic decay. 
Divergence in the rate of 51cr-release between control and 
inoculated cultures indicates that £. tularensis strain Schu S4 had a 
cytopathic effect on macrophages harvested from normal and BCG immunized 
mice. This divergence was not noted among macrophages harvested from 
mice which were specifically immunized with viable F. tularensis. 
The presence oE immune serum in the culture medium did not mitigate 
macrophage cytopathology. In fact, specific antibodies increased the 
susceptibility of normal and activated macrophages to bacterial 
destruction. This increase of susceptibility was greater among 
activated macrophages. 
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Table IX, Effect of tularensis strain Schu S4 on the release of ^^Cr 
from normal mouse peritoneal macrophages cultured in medium containing 
normal vs immune rabbit serum. 
Normal Immune 
serum serum 
Hours post-
inoculation Control Inoculated Control Inoculated 
0 104,747* 97,109 105,864 103,841 
12 83,081 80,256 82,918 83,443 
24 75,994 72,591 73,597 75,994 
36 69,087 65,204 66,270 59,747 
48 63,892 53,937 60,683 43,767 
60 59,191 40,349 57,126 29,239 
72 55,964 29,381 52,903 20,548 
84 54,154 24,277 49,867 16,976 
96 51,317 22,137 48,372 15,016 
108 47,163 19,642 46,229 11,799 
120 42,977 16,335 42,326 8,823 
^CPM remaining in adhered macrophages• 
Table X. Effect of _F. tularensis strain Schu S4 on the release of ^^Cr 
from macrophages harvested from BCG immunized mice, and cultured in 
medium containing normal vs immune rabbit serum^ 
Normal Immune 
serum serum 
Hours post-
inoculation Control Inoculated Control Inoculated 
0 165,297* 162,011 231,215 233,248 
12 128,317 131,764 189,477 188,216 
24 109,759 116,722 162,754 154,365 
36 100,629 105,432 145,464 112,699 
48 91,432 91,503 131,813 61,496 
60 85,694 66,732 119,684 35,835 
72 79,453 42,825 105,326 24,330 
84 78,124 34,075 102,305 21,436 
96 76,863 30,861 100,876 18,426 
108 73,149 27,102 98,347 14,872 
120 69,588 22,914 94,166 11,003 
^CPM remaining in adhered macrophages. 
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Table XI. Effect of tularensis strain Schu S4 on the release of ^^Cr 
from macrophages harvested from mice specifically immunized with 
_F. tularensis, and cultured in medium containing normal vs immune rabbit 
serum. 
Normal Immune 
serum serum 
Hours post- ————é* 
inoculation Control Inoculated Control Inoculated 
0 123,134* 136,005 214,023 206,383 
12 90,797 100,974 168,789 164,615 
24 83,910 93,141 138,108 141,229 
36 73,605 83,750 118,948 120,970 
48 66,970 75,786 108,859 109,002 
60 62,426 68,831 97,860 97,513 
72 59,116 64,247 93,360 93,426 
84 56,327 60,823 89,706 89,552 
96 52,712 56,952 85,474 84,216 
108 48,223 51,263 81,892 80,070 
120 45,271 47,030 77,857 75,409 
^CPM remaining in adhered macrophages. 
Table XII. The effect of various macrophage source/serum combinations on the rate of release of ^^Cr 
from macrophages in cultures inoculated with F. tularensis strain Schu S4. 
Normal BCG immune 2- t.- immune 
macrophages macrophages macrophages 
Normal Immune Normal Immune Normal Immune 
Hours post-
serum serum serum serum serum serum 
inoculation Contr. Inoc. Contr. Inoc. Contr. Inoc. Contr. Inoc. Contr. Inoc. Contr. Inoc. 
0 100.0* 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
12 79.3 82.6 78.3 80.4 77.6 81.3 81.9 80.7 73.7 74.2 78.9 79.8 
24 72.6 74.8 69.5 73.2 66.4 72.0 70.4 66.2 68.1 68.5 64.5 68.4 
36 66.0 67.1 62.6 57.5 60.9 65.1 62.9 48.3 59.8 61.6 55.6 58.6 
48 61.0 55.5 57.3 42.1 55.3 56.5 57.0 26.4 54.4 55.7 50.9 52.8 
60 56.5 41.6 54.0 28.2 51.8 41.2 51.8 15.4 50.7 50.6 45.7 47.2 
72 53.4 30.3 50.0 19.8 48.1 26.4 45.6 10.4 48.0 47.2 43.6 45.3 
84 51.7 25.0 47.1 16.3 47.3 21.0 44.2 9.2 45.7 44.7 41.9 43.4 
96 49.0 22.8 45.7 14.5 46.5 19.0 43.6 7.9 42.8 41.9 39.9 40.8 
108 45.0 20.2 43.7 11.4 44.3 16.7 42.5 6.4 39.2 37.7 38.3 38.8 
120 41.0 16.8 40.0 8.5 42.1 14.1 40.7 4.7 36.8 34.6 36.4 26.5 
Percent Cr remaining in adhered macrophages. 
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Fig. 11. Cytopathic effect of tularensis strain Schu S4 on macrophages 
harvested from normal mice, and cultured in medium containing 
no r m a l  v s  I m m u n e  r a b b i t  s e r u m .  I n o c u l a t e d  •  ; non i n o c u l a t e d  o ; 
normal serum in medium ; Immune serum in medium . 
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Fig. 12. Cytopathic effect of F^. tularensis strain Schu S4 on macrophages 
harvested from mice immunized with viable BCG, and cultured in 
medium containing normal vs immune rabbit serum. Inoculated • ; 
noninoculated o ; normal serum in medium ; immune serum 
in medium . 
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13. Cytopathic effect of IF. tularensls strain Schu S4 on macrophages 
harvested from mice specifically immunized with viable 
Z* tularensis, and cultured in medium containing normal vs 
immune rabbit serum. Inoculated # ; noninoculated o; normal 
serum in medium ; immune serum in medium . 
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Experiment - Growth of 2- tularensis strain S chu S4 in macrophage 
culture. 
This experiment was conducted to reconnoiter the growth kinetics 
of the bacterium in this particular vitro system. Normal macro­
phages, cultured in medium containing normal rabbit serum, were 
inoculated with 2» tularensis strain Schu S4 at a ratio of approximately 
10 bacteria per macrophage. Also, aliquots of culture medium alone 
were inoculated. Bacterial growth curves were constructed by standard 
plate count technique. 
Typical results presented in Table XIII and Fig. 14 show that the 
organism proliferated in the cell culture, however, the organism did 
not grow in the culture medium alone. Furthermore, the presence of 
specific antibodies in the culture medium alone, had no bactericidal 
effect of the organism. Other in vitro studies of _F. tularensis 
have obtained similar results (89). 
Experiment 4. - Growth of 2- tularensis strain Schu S4 in cell-free 
macrophage culture filtrate. 
Corroborative studies, which have also demonstrated an assoc­
iation between the presence of macrophages and bacterial growth in 
cell culture, have presumed that this proliferation is a consequence 
of intracellular multiplication (89,125). In order to determine if 
the bacteria are actually multiplying within the macrophage or 
whether it might be multiplying outside of the macrophage as a result 
of some possible secretory product or metabolite, serving as a 
nutrient, growth, curves of the organism were conducted in cell-free 
macrophage culture filtrates. 
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Table XIII. Growth of tularensis strain Schu 84 in macrophage 
culture and in culture media. 
Medium 
Days post- containing 
inoculation normal serum 
0 
1 
2 
3 
4.1 X 10 
4.3 X 10 
3.8 X 10 
4.2 X 10 
,4* 
Medium 
containing 
immune serum 
4.5 X 10* 
4.3 X 10^ 
4.7 X 10^ 
4.5 X 10^ 
Normal 
macrophages 
in medium 
containing 
normal serum 
4.4 X 10 
4.5 X 10 
3.9 X 10' 
1.2 X 10 
8 
Cell-free 
culture 
filtrate 
(normal serum) 
4.3 X 10 
2.8 X 10-
9.7 X 10' 
7.9 X 10 ,8 
^Number of bacteria per ml. 
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Fig. 14, Growth curves of K tularensis strain Schu S4 in culture media 
and in macrophage culture. Medium & normal serum # # ; 
medium & immune serum e # ; normal macrophages & normal 
serum o o; cell-free culture filtrate O o. 
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Macrophages were harvested from normal mice and cultured in medium 
containing normal rabbit serum. After 3 days of incubation, the 
culture medium was withdrawn and filtered through a 0.22/im syringe-
mounted Millipore^filter. Aliquots of the filtrate were inoculated 
with tularensis strain Schu S4 and bacterial growth curves were 
constructed. The results presented in Table XIII and Fig. 14 show 
that the bacteria proliferated in the absence of intact macrophages. 
Experiment _5. - Effect of various macrophage source/serum combinations 
on the growth of tularensis strain Schu S4 in cell culture. 
Macrophage cultures were set up as diagrammed in Fig. 1 and 
inoculated with IF. tularensis strain Schu S4. Bacterial growth 
curves were then constructed. 
Table XIV and Fig. 15 show the data from a typical experiment. 
Although the type of serum in the culture medium had no effect on the 
growth of the organism when the organism was inoculated in medium 
alone (Expt. 3), there was a significant difference when macrophages 
were present in the medium. Presence of specific antibodies in 
inoculated cell cultures suppressed bacterial growth. The only 
combination capable of completely inhibiting bacterial growth was 
macrophages harvested from tularensis immune mice, and cultured in 
medium containing immune serum. 
Table XIV. Effect of various macrophage source/serum combinations on the growth of tularensis 
strain Schu S4 in cell culture. 
Normal 
macrophages 
BCG immune 
macrophages 
F. tularensis 
immune 
macrophages 
Days post-
inoculation 
Normal 
serum 
Immune 
serum 
Normal 
serum 
Immune 
serum 
Normal 
serum 
Immune 
serum 
0 4.3 X 104* 4.0 X 104 4.2 X 104 4.5 X 104 3.9 X lo4 4.2 X 10^ 
1 4.2 X 10^ 4.1 X lO'^ 4.6 X 10^ 4.0 X 10^ 4.4 X 10^ 3.9 X 10^ 
2 4.8 X 10^ 1.8 X 10^ 7.6 X 10* 9.7 X 104 2.6 X 10* 3.9 X 10^ 
3 1.5 X 10® 3.7 X 10^ 3.3 X 10® 5.1 X 10^ 3.8 X 10^ 3.8 X lo'^ 
^Number of bacteria per ml. 
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Fig. 15. Effect of macrophage source/serum combinations on the growth of jF. tularensis 
strain Schu S4 in cell culture. 
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In vivo uptake of 2- tularensls strain Schj S4 and monocytogenes by 
mouse peritoneal cells 
Evidence has been accumulating which indicates that this organism 
may not be phagocytosed by peritoneal macrophages. Further investigat­
ion was conducted by determining the iji vivo clearance of bacteria 
from the peritoneal cavity of mice. Suspensions of F^. tularensis 
strain Schi S4 or monocytogenes were injected into the peritoneal 
cavities of mice. One hr after injection, the peritoneal cavities 
were lavaged and the exudates were separated into a cellular fraction 
and a supernatant fraction by centrifugation. In each case, the number 
of cell-associated or supernatant-associated bacteria was assayed. The 
data have been presented in Table XV as the percent total recoverable 
bacteria. It was found that Ij. monocytogenes became associated with 
the cellular fraction of the peritoneal exudate, whereas, F^. tularensis 
remained with the fluid fraction. 
To determine if antitularensis antibodies may be functioning as 
opsonins, groups of mice were injected with F^. tularensis strain Schu 
S4 which had been pretreated with immune rabbit serum. The bacteria 
were incubated in the immune serum at 37 ®C for 1 hr before ip. 
injection. This incubation was conducted at a prozone concentration 
of antibody to prevent bacterial agglutination. Likewise, bacteria 
were incubated in normal rabbit serum to serve as controls. Results 
are presented in Table XV. Pretreatment of the bacteria with specific 
antibodies caused a significant fraction of the inoculum to become 
cell-associated. Little interaction was noted between peritoneal 
cells and bacteria pretreated with normal rabbit serum. 
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Table XV. In vivo uptake of F^. tularensis strain Schu S4 and 
L. monocytogenes by mouse peritoneal cells . 
of total number of organisms recovered 
Challenge organism 
2" _t. Schu S4 
L. monocytogenes 
_t. Schu S4 pretreated 
with normal rabbit serum 
2» _t. Schu S4 pretreated 
with immune rabbit serum 
Cell 
associated 
7.0 ± 4.3 
96.0 ± 1.2 
3.6 ± 1,0 
21.8 ± 9.8 
Supernatant 
associated 
93.0 ± 4.3 
4.0 ± 1.2 
96.4 ± 1.0 
78.2 ± 9.8 
^Mice were challenged ip. One hour later their peritoneal cavities 
were lavaged, and the exudate separated into a supernatant fraction 
and a cellular fraction by centrifugation. 
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Exploratory studies were conducted to determine if strains of 
F. tularensis of differing virulences might differ in their association 
with the peritoneal cells or fluid. It was found that there was no 
significant difference in bacterial uptake attributable to the 
virulence of the organism (data not presented). 
An exploratory experiment was also conducted to in/estigate the 
possibility that F^. tularensis strain Schu S4 contained an antiphago­
cytic substance. This was done by injecting a mixed inoculum of 
Z* tularensis strain Schu S4 and L. monocytogenes and determining if 
the presence of _F. tularensis would modify the uptake of the Listeria. 
Bacterial plate counts of the respective exudate fractions were 
performed on a selective medium which did not support the growth of 
Z* tularensis. It was found that the uptake of monocytogenes 
by mouse peritoneal cells was not altered by the presence of 
F. tularensis strain Schu S4 (data not presented). 
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Fluorescent antibody staining of macrophages in cultures inoculated 
with 2' tularensis strain Schix S4 
The existence of any intracellu larly-located bacteria was 
probed by the use of fluorescein isothiocyanate-conjugated anti-
tularensis immunoglobulin. As positive controls, macrophage 
cultures were inoailated with suspensions of formalin-killed 
Coxiella burnetii and incubated for 2 days. The cultures were 
then washed 3 times with sterile saline, fixed in acetone at -70 
for at least 12 hr and stained with a homologous fluorescent 
conjugate. The presence of burnetii antigen within the cells 
was readily detected (Fig. 15). 
Macrophage cultures were inoculated with F. tularensis strain 
Schu S4 and incubated until cytopathology was apparent. The cells 
were processed as described above and stained. Fluorescent micro­
scopic examination did not reveal the presence of the organisms 
within the macrophages (Fig. 16). There was considerable fluor­
escence, however, along the external periphery of the cells. 
Staining of cells in noninoculated cultures showed that this 
peripheral fluorescence was not due to nonspecific adherence of the 
conjugate to the macrophage cell membrane. 
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Fig. 16i Mouse peritoneal adherent cells maintained in KPMI 
medium containing 20% rabbit serum, 2 days after 
exposure to formalin-killed C^. burnetii, stained by 
fluorescent antibody technique, showing intracellular 
localization of antigen. 750X. 
Fig. 17. Mouse peritoneal adherent cells maintained in RPMI 
medium containing 20% rabbit serum, 2 days after 
exposure to viable 2- tularensis strain Schu S4, 
stained by fluorescent antibody technique, showing 
the absence of intracellular localization of the 
organisms. 1250X. 
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CHAPTER IV 
DISCUSSION 
The results obtained in this investigation indicate that 
Francisella tularensis is in extracellular association with host 
mononuclear phagocytes during the disease process in the mouse. The 
first line of evidence supporting an extraphagocytic nature of this 
organism is its indif ference to an increased bactericidal capacity 
of an activated RES. In this study, viable BCG was used to activate 
macrophages and to induce nonspecific resistance. It has been shown 
that this induction resulted in significant increases in protection 
against known facultative intracellular parasites, but not against 
2" tularensis strain S chu S4. If _F. tularensis is such an intra­
cellular parasite, it is inconceivable that the increased bacter­
icidal capacity of the activated macrophages, which resulted in 
over a 10^-fold increase in protection against challenge of mice 
with I^. monocytogenes, should not be able to even mitigate tularemic 
infection. 
Further evidence which indicates an extraphagocytic nature of 
this organism is its lack of association with mouse peritoneal cells 
in vivo. I^. monocytogenes is known to be a facultative intracellular 
organism. As expected, L. monocytogenes became associated with the 
cellular portion of the exudate when injected into the peritoneal 
cavities of mice. £. tularensis strain Schu S4, however, remained 
with the fluid portion of the exudate. Taplits and Myrvik (124) 
obtained similar results using F. tularensis strain LVS. These 
findings tend to suggest that an antiphagocytic substance might be 
present on the bacterial cell wall. Proctor e^ (102) assessed 
phagocytosis of 2- tularensis by rhesus monkey peripheral poly­
morphonuclear neutrophils (PMN) by the use of autoradiography, 
electron microscopy and biochemical techniques. They reported that 
F^. tu larensis was not ingested by PMN in the absence of immune serum 
and considered the possibility that this evasiveness was due to an 
antiphagocytic substance on the surface of the bacterium. They were 
unable to establish the existence of such a substance. In this 
laboratory, attempts to demonstrate an antiphagocytic substance were 
also unsuccessful. The presence of 2- tu larensis strain Schu S4 did 
not modify the uptake of 1^. monocytogenes by mouse peritoneal cells 
in vivo. 
Additional evidence of lack of intraphagocytic occurrence of 
2. tularensis strain Schu S4 was obtained by direct fluorescent 
microscopic examination of inoculated cultures. Fluorescent antibody 
staining of moribund peritoneal macrophages in inoculated cultures 
did not reveal the presence of intracellular antigen. Demonstration 
of intracellular C^. burnetii antigen with a homologous conjugate 
indicates that this technique was capable of detecting antigens so 
located. Also, staining of bacterial smear controls showed that 
the conjugate did indeed have a specificity for 2* tularensis. A 
fluorescent haze was observed along the external periphery of 
numerous macrophages. It was found that this was not due to non­
specific adherence of the conjugate to the macrophage. Functional 
testing of macrophages by latex particle ingestion revealed that 
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these cells were avidly phagocytic. Adherence of bacteria to 
macrophages without subsequent ingestion would be intriguing. Such 
an occurrence, however, would be inimical with the results obtained 
in the in vivo uptake experiment. A similar phenomenon was reported 
by Merriott et al. (85) in F. tularensis-inE ected mouse L cells. 
They noted that this occurrence was influenced by the concentration 
of serum in the culture medium. The effect of serum concentration 
was not investigated in this study. Although the observance of 
peripheral fluorescence requires more investigation, emphasis is 
placed on the fact that the organisms were not detected inside of 
the macrophages. Other studies, however, have detected tularensis 
within various types of host cells by means of fluorescent antibody 
technique (55,85,134). 
From the results of this study alone, an assertion that 
_F. tularensis strain Schu S4 is a strict extracellular parasite would 
be an unwarranted generalization. The evidence of extracellular 
association by tularensis presented in this investigation may 
apply only to mouse peritoneal macrophages. It is quite possible 
that the phagocytic avidity of mouse peritoneal macrophages for 
F. tularensis strain Schu S4 may differ from other animal species, or 
even from other cell types within the mouse. Extrapolation to other 
animal models and/or cell systems may not be supportable. All the 
evidence presented in this study, however, indicates that 2* tularensis 
strain Schu S4 is in extracellular association with mouse peritoneal 
macrophages. 
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Scientific literature contains numerous references which are 
responsible for the belief that tularensis is a facultative 
intracellular parasite. Nutter and Myrvik (89) repordetly have 
grown the organism in cultured alveolar macrophages. Thorpe and 
Marcus (125) infected cultures of alveolar and peritoneal macro­
phages from rabbits and guinea pigs with various strain of 
2" tularensis and observed the bacteria within the cultured cells. 
Proctor ̂  (102) incubated rhesus monkey peritoneal macrophages 
with %-labelled LVS organisms and observed intracellular local­
ization of the label. White e_t (134) have provided revealing 
fluorescent photomicrographs of monkey alveolar macrophages 
containing 2- tularensis strain Schi S4 in the cytoplasm of the 
phagocytes. 
It mist be stated that, although there is good evidence of an 
intraphagocytic nature of this organism in animal species other than 
the mouse and in cell types other than peritoneal cells, such e/idence 
is scanty as far as the mouse peritoneal macrophage system is 
concerned. The possibility of a unique phagocytic avidity among 
mouse peritoneal macrophages has been suggested by Thorpe and Marcus 
(126). Findings presented in this study are not inconsistent with 
the literature. 
Studies which have been cited in support of an intracellular 
nature of this organism have often been presumptuous in assuming that 
bacterial proliferation and cytopathology are a consequence of intra­
cellular multiplication. Nutter and Myrvik (89) inoculated 
suspensions of rabbit peritoneal macrophages with E^. tularensis 
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strain Schu S4 and noted that the bacteria proliferated. They 
stated that this increase was "most probably" the result of intra­
cellular multiplication. Actual phagocytosis of the bacteria has 
often only been inferred, rather than proved. Thorpe and Marcus 
(125) determined the concentration of bacteria within phagocytes 
in vitro, and also ingestion and digestion rates of the bacteria, 
by light microscopy. The small size (0.2-0.3 x 0.7y^m) and the 
extreme pleomorphlsm of this organism, coupled with the granularity 
of the macrophage cytoplasm, appears to this writer, and also to 
others (83,102), to preclude identification of the organism within 
phagocytes by conventional light microscopy. 
Correlation has been dimonstrated in this study between bact­
erial growth in cell culture medium and the presence of macrophages. 
The In vItro system of Nutter and Myrvik (89) produced similar 
findings. An association between bacterial growth in cell culture 
medium and the presence of macrophages does not necessarily imply 
that the bacterial growth is occurring within the macrophage. The 
location of proliferation was investigated in this study by monitor­
ing the growth of the organism in macrophage culture filtrates. The 
organism was found to grow in the cell-free culture filtrate as 
luxuriantly as in the cell culture. It is astonishing that none of 
the studies reviewed by this writer have considered the possibility 
of this occurrence. Apparently, macrophages in this system released 
some excretory product or metabolite which provided a growth 
requirement for this fastidious bacterium. The existence of such 
extracellular macrophage products is well established (6, 97,117, 
131,133). Limited characterization of this factor was conducted. 
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It was heat stable (56 ®C for 30 min). Bacterial growth curves in 
culture media containing varying dilutions of the filtrate were 
constructed. It was found that as the concentration of the filtrate 
decreased, the rate of growth of the bacteria decreased and also 
that the number of organisms eventually attainable decreased. This 
suggests that the nature of this factor is not vitamin-like, but 
rather, that it may be a consumable product. Further character­
ization is beyond the scope of this investigation. The important 
point is that the correlation which can be shown between bacterial 
proliferation and the presence of macrophages in this system, may 
be explainable in terms of extracellular growth. 
Numerous studies have recently been reported which also suggest 
an extraphagocytic nature of this organism. Proctor et al. (102) 
found that F^. tularensis resisted phagocytosis by hi man, monkey and 
rat PMN in vitro. They postulated that this phagocytic evasiveness 
deleted one of the possible host defense mechanisms and permitted 
early dissemination of the organism to specific target tissues. 
Taplits and Myrvik (124) observed that Listeria were rapidly 
eliminated from the peritoneal ca/ity of nice challenged ip., 
whereas F. tularensis strain LVS maintained a steady state population. 
They suggested that F^. tu larensis may be able to grow extracellular ily 
and eventually overcome the host defense machanisms. Powanda et al. 
(99) studied metabolic sequelae induced in rats by infection with 
2. tu larensis strain Schu S4. They concluded that tu larensis 
in nonimmune rats eludes the RES." 
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The subject of tumoral iiwolvment in resistance to tularemia 
remains an area oE controversy. Specific antibodies havre generally 
been believed to be only of secondary importance in imnunity to 
murine tularemia. Passive transfer of serum from resistant mice has 
repeatedly failed to protect normal recipients against challenge with 
fully virulent strains of 2- tularensis (70,80). Claflin (20) found 
that specific immune serum from mice imnunized with LVS was incapable 
of protecting mice from even a low challenge dose of 2- tularensis 
strain Schu S4. Hirthermore, increasing the titer and the quantity 
of the antiserum did not produce resistance, and led him to conclude 
that "specific antibodies, per se, are not of primary importance in 
immunity to tularemia." Also, opsonization of the bacteria prior 
to challenge was not found to increase resistance. Peckinpaugh (95) 
observed that although comparable levels of antibodies were present 
in groups of mice immunized with nonviable and viable vaccines, the 
resistance of the 2 groups of mice to infection with fully virulent 
strains of tularensis was not comparable. Thorpe and Marcus 
(125,126) reported that the type of serum (normal vs immune) in 
cell culture media did not significantly affect the ingestion of 
F. tularensis by rabbit or guinea pig peritoneal macrophages in 
vitro. Similar findings were reported by Natter and Myrvik (89). 
Serum antibodies are not always an indication of the Immine state. 
Studies cited in the preceeding paragraph discount the import­
ance of hi moral immunity in host resistance to infection with 
2' tularensis. The resuIts presented here, conflict with those 
findings. This study presents evidence that antitularensis isnauno-
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globulins may have an important role in the expression of immunity 
in mice. This may seem in contradiction with the finding that the 
establishment of a specific humoral response in mice by active or 
passive immunization did not alter the course of infection by 
Z.' tailarensis strain Schu S4, a finding in agreement with numerous 
other studies (20,21,95). However, further investigation revealed 
some interesting insights. In conjunction with an activated RES, 
specific antibodies resulted in measurable protection against 
challenge with 2- tu larensis strain Schu S4. luoma (70,71) 
conducted similar experiments with 2- tularensis strain 425 F^G 
and also found that a combination of humoral and cellular factors 
resulted in protection. This increase in protection was only minor, 
and of no practical significance to the host, but, nevertheless, it 
does indicate that antibodies may participate in an immune response 
to this organism. The finding that the presence of specific anti­
bodies in cell culture media resulted in differences in cytopathology 
of mouse peritoneal macrophages in inoculated cultures also indicates 
humoral involvement. Destruction of normal and BCG imraine macrophages 
by F. tularensis strain Schu S4 was greater when the cultures 
contained media with immune serum. This finding was unexpected. It 
is interesting that specif ic antibodies can be shown to increase the 
susceptibility of host cells to a pathogen. This will be discussed 
later. Antibody involvement was also indicated by an inhibitory 
effect of immune serum on bacterial growth in cell culture. When 
bacteria were inoculated into medium in the absence of macrophages, 
it was found that the immune serum in the culture medium did not 
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inhibit bacterial growth any more than normal serum. When macro­
phages were present in the culture medium, however, immune serum 
resulted in a general suppression of bacterial growth in comparison 
with normal serum. Although there are indications of a protective 
action of antibodies during tularemic infection in mice, the exact 
nature of this interaction is uncertain. 
Other studies have also challenged the contention that anti­
bodies are unimportant in resistance to tularemia. Luoma (70,71) 
found that cyclophosphamide, an immunosuppressive agent effective 
in eliminating the antibody producing cell, abolished immunity to 
2. tularensis strain 425 F^G. She concluded that immunity to 
Z' tularensis results from a conbination of specific and nonspecific 
immunity. Proctor et al. (102) found that specific antibodies were 
required for the phagocytosis of 2' tularensis by human, monkey and 
rat PMN. Taplits and Myrvik (124) monitored the growth of 
F. tu larensis strain LVS in the organs of infected mice and found 
that the decline of the LVS population in these mice coincided with 
the appearance of specific agglutinins. Eigelsbach et al. (35) 
showed that adaptive transfer of spleen cells from Schu S4 vaccinees 
was often protective only when antitularensis serum was also admin­
istered. 
In this study, evidence has been obtained which suggests that 
the antibodies may be activg as opsonins. It was found that the 
presence of immune serum in the medium of inoculated cultures 
increased the destruction of nonimmune macrophages by the bacteria. 
A similar phenomenon was also observed by Thorpe and Marcus (126). 
72 
One possible explanation is that the antibodies opsonized the bacteria. 
Opsonization resulted in the phagocytosis of the bacteria by the 
macrophages. Hav'ing been phagocytosed, the bacteria were placed in 
a position where the phagocytes were more vulnerable to the cytocidal 
activity of the bacteria. It was also found that immune serum 
enabled the macrophage cultures to more effectively inhibit the 
growth of this organism in cell cultures. Bacterial growth was 
suppressed in cultures containing immune serum. The growth curves 
of the organism in medium containing normal vs immune serum without 
macrophages, demonstrated that this suppression was not due to 
complement-mediated bacteriolysis. Considering the findings that; 
1.) the organisms were not detectable within the cells of inoculated 
macrophage cultures containing normal serum, 2.) the organisms were 
capable of extracellular proliferation in such cultures, and that 
3.) specific antibodies by themselves were not deleterious to the 
viability of the organism, the suppression of bacterial growth in 
cell cultures containing immune serum could be explained by reason­
ing that the specif ic antibodies functioned as opsonins and resulted 
in the engulfment of the bacteria into the unfavorable en/ironment 
within the phagocyte. Pretreatment of bacteria with homologous 
antibodies increased bacterial association with peritoneal cells 
in vivo. This confirms findings by Taplits and Myrvik (124). 
Although this increase was not as dramatic as hoped, it is statis­
tically significant. 
Other evidence exists which also supports an opsonic nature of 
antibodies in the immune response to tularemic infection. Claflin (20) 
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found that the clearance of virulent tularemia bacilli from the 
blood of mice was enhanced when specific antibodies were passively 
into the mice. Proctor ̂  (102) demonstrated that immune 
serum enabled monkey PMN to engulf F^. tularensis in vitro. Taplits 
and Myrvik (124) reported that mice had difficulty in removing 
Z.' tularensis strain LVS from the peritoneal canity before the 
appearance of specific antibodies. 
Resistance to tularemia has been shown to be dependent on a 
state of altered reactivity of the host cells. Results obtained in 
this investigation confirm that dependency. The exact mechanism by 
which host cells become specifically sensitized and exert antibact­
erial properties is still undefined. Only macrophages harvested 
from mice specifically immunized with viable tularemia organisms 
were found to be resistant to the cytopathic effect of F. tularensis 
strain Schi S4. Also, only macrophages from this source were capable 
of completely inhibiting bacterial growth. Macrophages from other 
sources apparently lacked some specific, altered, intrinsic quality. 
Immunization with a non/iable antigen did not result in protect­
ion against challenge by fully virulent strains of %. tularensis. 
Van der Meer (130) suggested that the inability of nonviable 
vaccines to protect against some infections may be due to rapid and 
extensive digestion of the antigen. They found that complete 
digestion of previously killed Listeria did not result in protection, 
but that this non/iable vaccine became protective when macrophage 
activity was impaired by the addition of polyanions. Incomplete 
processing of nonviable antigens could result in continued antigenic 
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stimulation and may be a prerequisite for protection. 
The experiment which was conducted to investigate the effect 
of various macrophage source/serum combinations on the growth of 
jF. tularensis strain Schu S4 in cell culture produced some revealing 
results which may serve to clarify and unite the results obtained 
elsewhere in this study. It was found that macrophages harvested 
from resistant mice were able to suppress bacterial growth only 
when specific antibodies were present in the system. It was only 
these macrophages which posessed the forementioned ability to 
inactivate ingested organisms. Although these phagocytes had the 
ability to destroy the organisms* this ability was ineffectual, 
unless antibodies were available to opsonize the organisms. In 
the absence of antibodies, the bacteria may not be ingested, and 
proliferate extracellularily and escape intraphagocytic destruction. 
In the presence of antibody, the bacteria are presumable opsonized 
and thereby placed in a position where inactivation can occur. 
Immunity of mice to tularensis strain Schu S4 thus appears to 
require specific sensitization of reticuloendothelial cells. This 
enables the host to inactivate the organism. Immunity appears to 
also require specific antibodies. These are necessary to expose the 
organisms to the bactericidal machinery in the intracellular 
environment of the sensitized macrophage. With this in mind: 1.) 
the inability of viable BCG to induce nonspecific immunity effective 
against challenge with this organism can be explained by reasoning 
that specific antibodies were absent; 2.) the inability of active 
immunization with EEA or passive administration of immune serum to 
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result in protection against infection can be explained by reasoning 
that the macrophages lacked the functional capacity to inactivate 
the ingested bacteria; 3.) the protection which resulted from the 
combination of RES activation and humoral immunity can be explained 
by reasoning that the specific antibodies opsonized the bacteria 
and exposed them to the increased bactericidal properties in the 
intracellular environment of the BCG activated macrophages; 4.) the 
finding that the susceptibility of normal and BCG immune macrophages 
to bacterial cytopathology was greater in cultures containing 
immune serum than in cultures containing normal serum can be 
explained by reasoning that the specific antibodies in the immune 
serum positioned the bacteria in a location where the macrophages 
are more vulnerable to the cytocidal activity of the bacteria and 
finally, 5.) inhibition of bacterial growth in macrophage culture 
can be expected to occur only in cultures containing immune serum 
and cells harvested from mice specifically immunized with viable 
organisms. 
The cytopathology which was noted in inoculated cultures 
should be accountable. Intracellular bacterial proliferation 
leading to rupture of the macrophage is improbable in light of the 
lack of any evidence of intracellular existence of the organisms in 
this cell type (in the absence of opsonins). Some bacterial factor 
directed against the macrophage is indicated. F^. tularensis is not 
known to produce any toxins, although there are reports that viable 
tularensis organisms have toxic properties (11,39,64,88,89). 
Bacterial lipopolysaccharides are known to be cytotoxic to macrophages 
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however, no classical endotoxin has been demonstrated in _F. tularensis. 
The possibility of a bacterial product toxic to macrophages in this 
system was briefly investigated by adding cell-free bacterial culture 
filtrates to macrophage cultures and observing for any resulting 
cytotoxicity. ^^Cr-release methodology showed that this bacterial 
culture filtrate did have a slight cytotoxic effect on the cultured 
macrophages. Due to a time limitation, further investigation was 
not conducted. Clearly, more research into this matter would be in 
order. 
Although the phagocytic leucocyte has been implicated as the 
receptor cell for many facultative intracellular bacteria, evidence 
presented in this study indicates that this may not be the case 
regarding tularensis strain Schu S4 in the mouse. Tularemic 
lesions, including hemorrhagic necrosis of the spleen, focal necrosis 
of the liver and widespread degenerative tissue changes, clearly 
indicate cellular destruction in the disease process. tularensis 
is known to infect various cell types on non-lymphoid origin. 
Merriott £t (85) found that ]F. tularensis strain Schu S4 was 
highly infectious for mouse L cells, bovine kidney cells and human 
amnion cells vitro, and that rapid bacterial multiplication 
occurred in the cytoplasm of these various cells. Powanda et al. 
(99) maintain that ]?. tularensis strain Schu S4 in nonimmune rats 
infects the parenchymal cells of the liver and spleen. Hall et al. 
(55) and White ̂  al. (134) challenged rhesus monkeys with aerosols 
of F. tularensis and demonstrated by immunofluorescence that the 
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organisms were present in the epithelial cells of the respiratory 
bronchioles and adjacent alveoli. Downs e^ a^. (29) have shown 
that the organisms multiply abundantly in the tissues of embryonated 
chicken and duck eggs. Shepard (114) has shown that 2' tularensis 
is engulfed by HeLa cells. It may well be that such non-lymphoid 
cells comprise the primary target tissues in the disease process 
during tularemia in the mouse. 
The anomalies between the ̂  vitro findings in this study and 
other similar studies may be due, in part, to variable inherent to 
such in vitro systems. Many studies have employed macrophages which 
were obtained from inflammatory exudates stimulated by various types 
of chemotactic agents or irritants. The phagocytosis of organisms 
by peritoneal macrophages has been shown to be influenced by these 
procedures (24,3 8). McElree and Downs (83) demonstrated that macro­
phages exhibited a strikingly increased ability to ingest F. bilarensis 
when irritants were used to elicit the exudates. In this study, 
however, non-inflammatory cells, harvested from untreated peritoneal 
cavities, were used, so as to simulate more closely, the in situ 
physiological state of the cells. The source of animal serum best 
suited for the culture and parasitization of phagocytes also remains 
an open question (85). Guinea pig and calf sera have been reported 
to enhance significantly the phagocytosis of %. tularensis by 
peritoneal macrophages vitro, whereas, rabbit serum failed to 
enhance ingestion oE the organisms (83). Shepard (112) showed that 
HeLa cells are more phagocytic and more susceptible to infection with 
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tubercle bacilli when cultured in mediua containing horse serum 
than in media containing human serum. These variables might account 
for the different results obtained in this study. 
Virulence factors of F. tularensis are obscure. The results 
of this study shed little light on this issue. It appears, though, 
that virulence can not be equated with the degree of association of 
the organisms with host phagocytes. In vivo uptake experiments 
have shown that avirulent and virulent strains are equally dissociated 
from mouse peritoneal macrophages. Other studies which have used 
cells capable of normally engulfing this organism have demonstrated 
that strains of varying virulences are equally phagocytosed (85). It 
is personally felt that virulence may be a function of the organisms 
metabolism and nutritional requirements. Strains of reduced virulence 
have been observed to grow more slowly on plate culture. Plate counts 
of such strains are lower and irregular and colonial characteristics 
vary considerably. Less virulent strains have also been noticed to 
be more sensitive to their environment. It is set forth that the 
virulence of ]?. tularensis is not associated with phagocytic 
evasiveness, but rather, that virulence of the organism parallels its 
ability to persist and multiply in the host, either intracellularly 
or extracellular ly. 
Evidence has been presented in this investigation which 
indicates that F^. tn larensis strain Schu S4 may not ordinarily be 
ingested by reticuloendothelial cells in the nonimmune mouse. Withr-
out phagocytosis, the organisms might be able to proliferate extra-
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phagocytically, disseminate to sites of specific target tissues and 
eventually wercome other host defense mechanisms. 
Resistance in mice to tularemic infection apparently reauires 
the cooperation of both humoral and cellular immune mechanisms. 
Host resistance may depend on the functional capacity of the host 
cells to inactivate the organism. Resistance may also require the 
opsonic effect of specific antibodies so that inactivation can be 
accomplished. 
Host immunity, and survival of parasites, depend on a complex 
and delicate balance of host-parasite interplay. The mechanisms of 
immunity which arise in the host to rid it of intracellular parasites 
are not fully understood. The results of this study, although 
inconclusive, may serve to clarify some of the enigmas which have 
persisted over the years regarding host-parasite interaction during 
tularemia. 
CHAPTER V 
SUMMARY 
This study has presented evidence which indicates that 
K' tularensis is in extracellular association with host mononuclear 
phagocytes during the disease process in the mouse. The course of 
infection of mice with tu larensis strain S chu S4 was not mitigated 
by the increased bactericidal capacity of a BCG activated RES. When 
injected into the peritoneal canity of mice, _F. tu larensis strain 
Schu S4 became associated with the fluid portion of the peritoneal 
exudate, whereas, I^. monocytogenes, when injected ip. became assoc­
iated with the cellular portion of the exudate. Fluorescent anti­
body staining of macrophage cultures inoculated with _F. tularensis 
strain Schu S4 did not reveal the presence of intracellular 
organisms. This evasiveness does not appear to be due to an anti­
phagocytic substance on the bacterial cell surface. It is 
postulated that in the nonimmune mouse, 2- tularensis strain Schu 
S4 may not ordinarily be ingested by phagocytes and may be able to 
w ercome host defenses while in extracellular association with the 
host. 
Contrary to the generally-held belief that specific antibodies 
ar only of secondary importance in immunity to tularemia, evidence 
is presented in this study which indicates that antibodies may have 
a vital role in resistance in mice. Humoral immunity in conjunct­
ion with a nonspecifically activated RES resulted in a degree of 
protection against challenge with F. tularensis strain Schu S4. 
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^^Cr-release assays showed that immune serum influenced the 
cytopathic effect of tularensis strain Schu S4 on cultured 
macrophages. Pretreatment of bacteria with immune serum increased 
their association with peritoneal cells in vivo. Cultured macro­
phages were able to suppress bacterial growth only when specific 
antibodies were present in the culture medium. Specific anti­
bodies may function in host resistance by promoting phagocytosis 
and controlling dissemination of the infecting organisms. 
Resistance in mice to tularemic infection appears to require 
the synergistic cooperation of both humoral and cell-mediated 
mechanisms of imnunity. Cellular sensitization is required for 
inactivation of the organisms. Specific antibodies are also 
necessary to aid ingestion, so that inactivation can occur. 
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